vs

Side-by-side financial comparison of GENCO SHIPPING & TRADING LTD (GNK) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

GENCO SHIPPING & TRADING LTD is the larger business by last-quarter revenue ($109.9M vs $83.1M, roughly 1.3× PROCEPT BioRobotics Corp). GENCO SHIPPING & TRADING LTD runs the higher net margin — 14.0% vs -38.1%, a 52.1% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 10.8%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs -3.3%).

Genco Shipping & Trading Ltd is a global dry bulk shipping enterprise that operates a diversified fleet of bulk carriers, transporting essential commodities including iron ore, coal, grain, and steel products across major international trade routes, serving industrial, manufacturing, and commodity trading clients worldwide.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

GNK vs PRCT — Head-to-Head

Bigger by revenue
GNK
GNK
1.3× larger
GNK
$109.9M
$83.1M
PRCT
Growing faster (revenue YoY)
PRCT
PRCT
+9.4% gap
PRCT
20.2%
10.8%
GNK
Higher net margin
GNK
GNK
52.1% more per $
GNK
14.0%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
-3.3%
GNK

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
GNK
GNK
PRCT
PRCT
Revenue
$109.9M
$83.1M
Net Profit
$15.4M
$-31.6M
Gross Margin
64.9%
Operating Margin
17.3%
-4.1%
Net Margin
14.0%
-38.1%
Revenue YoY
10.8%
20.2%
Net Profit YoY
21.6%
-27.9%
EPS (diluted)
$0.36
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GNK
GNK
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$109.9M
$76.4M
Q3 25
$79.9M
$83.3M
Q2 25
$80.9M
$79.2M
Q1 25
$71.3M
$69.2M
Q4 24
$99.2M
$68.2M
Q3 24
$99.3M
$58.4M
Q2 24
$107.0M
$53.4M
Net Profit
GNK
GNK
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$15.4M
$-29.8M
Q3 25
$-1.1M
$-21.4M
Q2 25
$-6.8M
$-19.6M
Q1 25
$-11.9M
$-24.7M
Q4 24
$12.7M
$-18.9M
Q3 24
$21.5M
$-21.0M
Q2 24
$23.5M
$-25.6M
Gross Margin
GNK
GNK
PRCT
PRCT
Q1 26
64.9%
Q4 25
60.6%
Q3 25
64.8%
Q2 25
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Operating Margin
GNK
GNK
PRCT
PRCT
Q1 26
-4.1%
Q4 25
17.3%
-40.6%
Q3 25
3.1%
-27.8%
Q2 25
-5.3%
-28.0%
Q1 25
-13.7%
-39.7%
Q4 24
14.7%
-28.9%
Q3 24
24.2%
-38.4%
Q2 24
24.6%
-50.3%
Net Margin
GNK
GNK
PRCT
PRCT
Q1 26
-38.1%
Q4 25
14.0%
-39.1%
Q3 25
-1.3%
-25.7%
Q2 25
-8.4%
-24.7%
Q1 25
-16.7%
-35.8%
Q4 24
12.8%
-27.6%
Q3 24
21.6%
-35.9%
Q2 24
21.9%
-48.0%
EPS (diluted)
GNK
GNK
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$0.36
$-0.54
Q3 25
$-0.02
$-0.38
Q2 25
$-0.16
$-0.35
Q1 25
$-0.28
$-0.45
Q4 24
$0.29
$-0.34
Q3 24
$0.49
$-0.40
Q2 24
$0.54
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GNK
GNK
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$55.5M
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$896.5M
$347.7M
Total Assets
$1.1B
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GNK
GNK
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$55.5M
$286.5M
Q3 25
$90.0M
$294.3M
Q2 25
$35.4M
$302.7M
Q1 25
$30.2M
$316.2M
Q4 24
$43.7M
$333.7M
Q3 24
$46.7M
$196.8M
Q2 24
$42.0M
$214.1M
Total Debt
GNK
GNK
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
GNK
GNK
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$896.5M
$365.9M
Q3 25
$885.9M
$380.3M
Q2 25
$891.6M
$385.8M
Q1 25
$903.2M
$389.2M
Q4 24
$926.7M
$402.2M
Q3 24
$929.9M
$241.2M
Q2 24
$921.8M
$251.8M
Total Assets
GNK
GNK
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$1.1B
$508.1M
Q3 25
$1.1B
$511.5M
Q2 25
$1.0B
$513.1M
Q1 25
$1.0B
$519.4M
Q4 24
$1.1B
$534.0M
Q3 24
$1.0B
$374.1M
Q2 24
$1.1B
$374.4M
Debt / Equity
GNK
GNK
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GNK
GNK
PRCT
PRCT
Operating Cash FlowLast quarter
$15.9M
Free Cash FlowOCF − Capex
$15.6M
FCF MarginFCF / Revenue
14.2%
Capex IntensityCapex / Revenue
0.3%
Cash ConversionOCF / Net Profit
1.03×
TTM Free Cash FlowTrailing 4 quarters
$28.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GNK
GNK
PRCT
PRCT
Q1 26
Q4 25
$15.9M
$-10.3M
Q3 25
$7.7M
$-6.6M
Q2 25
$5.4M
$-15.0M
Q1 25
$2.9M
$-17.0M
Q4 24
$30.0M
$-32.4M
Q3 24
$35.6M
$-18.8M
Q2 24
$29.0M
$-15.7M
Free Cash Flow
GNK
GNK
PRCT
PRCT
Q1 26
Q4 25
$15.6M
$-12.2M
Q3 25
$6.5M
$-9.5M
Q2 25
$4.3M
$-17.8M
Q1 25
$2.3M
$-18.8M
Q4 24
$29.3M
$-33.6M
Q3 24
$34.7M
$-19.0M
Q2 24
$27.9M
$-16.8M
FCF Margin
GNK
GNK
PRCT
PRCT
Q1 26
Q4 25
14.2%
-15.9%
Q3 25
8.2%
-11.4%
Q2 25
5.3%
-22.5%
Q1 25
3.2%
-27.2%
Q4 24
29.5%
-49.2%
Q3 24
34.9%
-32.6%
Q2 24
26.1%
-31.4%
Capex Intensity
GNK
GNK
PRCT
PRCT
Q1 26
Q4 25
0.3%
2.4%
Q3 25
1.5%
3.4%
Q2 25
1.3%
3.5%
Q1 25
0.9%
2.7%
Q4 24
0.7%
1.7%
Q3 24
0.9%
0.4%
Q2 24
1.1%
2.0%
Cash Conversion
GNK
GNK
PRCT
PRCT
Q1 26
Q4 25
1.03×
Q3 25
Q2 25
Q1 25
Q4 24
2.37×
Q3 24
1.66×
Q2 24
1.24×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GNK
GNK

Segment breakdown not available.

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons